AXL tyrosine kinase promotes tumor progression through AKT/GSK-3β/β-catenin signaling, β-catenin nuclear-translocation-induced SNAIL transcription, and MMP-2 and MMP-9 activation. This evidence concerns the gene AKT1 and neoplasm.